SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial

This study will test a web-based supportive care program called the Support, Communication, and Information Program for Prostate Cancer - Interactive (SCIPI). SCIPI provides men with localized prostate cancer and their families with easy-to-understand information, tools to prepare for discussions with their doctors, and opportunities for social support. The purpose of this pilot study is to determine whether it is feasible to integrate SCIPI in prostate cancer clinical care via the electronic medical record and whether SCIPI may improve patients' confidence in making treatment decisions and their overall quality of life compared with usual care. The study will include patients who are newly diagnosed with prostate cancer. Participants will be randomly assigned to use SCIPI or to receive usual care, and information will be collected over time about their experiences, decision-making, and quality of life.

NCT Number	NCT07280897
Lead Sponsor	The University of Texas Health Science Center at San Antonio Collaborators: University of North Carolina, Chapel Hill, University of Kansas Medical Center, University of California, San Diego
Conditions	Prostate Cancer
Enrollment	200 participants
Start Date	2026-10-01
Primary Completion	2029-09-29 (estimated)
Study Completion	2029-09-29 (estimated)
Updated on ClinicalTrials.gov	2025-12-19